The problem is that epidemiologists as well as economists appear to be planning for a vaccine coming down the pipeline in as little as six months, but a broadly used vaccine is likely to take two to three years in his 'most optimistic' estimation NEW YORK : A recovering US stock market may be pricing in too much optimism over the near-term potential of a vaccine to prevent the spread of the novel coronavirus.
An Oxford University scientist went so far as to tell The Times earlier this month that a vaccine could be ready by September, well ahead of guidance from US agencies that have suggested it is likely to take a year or more. “Such comments make having a vaccine and having one in this timeframe seem a foregone conclusion.